Lief Fenno
lief.fenno@austin.utexas.edu
The Fenno lab at the University of Texas Austin works at the intersection of molecular/viral engineering, neuroscience, and psychiatry, to develop and apply novel strategies to manipulate targeted neural circuits for both basic and translational application. On-going work includes (engineering) AAV payload and targeted delivery optimization, and development of genetically encoded synaptic gain modulators; (biology) characterizing the role of gliotransmitters and opioid neuropeptides in shaping cortical information flow across neural circuits, with relevance to human psychiatric illness. The lab is funded by the Clayton Foundation for Research, The W.M. Keck Foundation, the BD2 Foundation, and the State of Texas STARs fund. Lief Fenno, MD, PhD is a psychiatrist and neuroscientist who developed optogenetic tools and multiplexed AAV delivery strategies with Karl Deisseroth at Stanford University and applied these to causally investigate neural phenomena from human patients with Autism, Schizophrenia, and Anxiety. The group welcomes scientists from diverse backgrounds, is largely international, and is able to support visa needs.
Keywords: AAV, gene therapy, molecular tool development, neuroscience, and psychiatry/neurology.